Amino Acids

, Volume 43, Issue 1, pp 183–194 | Cite as

Protective immunity provided by a new modified SERA protein peptide: its immunogenetic characteristics and correlation with 3D structure

  • Adriana Bermúdez
  • Armando Moreno-Vranich
  • Manuel E. PatarroyoEmail author
Original Article


The serine repeat antigen (SERA) protein is a leading candidate molecule for inclusion as a component in a multi-antigen, multi-stage, minimal subunit-based, chemically synthesised anti-malarial vaccine. Peptides having high red blood cell binding affinity (known as HABPs) have been identified in this protein. The 6733 HABP was located in the C-terminal portion of the 47-kDa fragment while HABP 6754 was located in the C-terminal region of the 56-kDa fragment. These conserved HABPs failed to induce an immune response. Critical red blood cell binding residues and/or their neighbours (assessed by glycine-analogue scanning) were replaced by others having the same mass, volume and surface but different polarity, rendering some of them highly immunogenic when assessed by antibody production against the parasite or its proteins and protection-inducers against experimental challenge with a highly infectious Aotus monkey-adapted Plasmodium falciparum strain. This manuscript presents some modified HABPs as vaccine candidate components for enriching our tailor-made anti-malarial vaccine repertoire, as well as their 3D structure obtained by 1H-NMR displaying a short-structured region, differently from the native ones having random structures.


SERA 5 NMR Structure Malaria vaccine 



We would like to thank Jason Garry for helping in the translation of the manuscript, Sylvain Meguellatni for helping with technical support regarding Bruker equipment and Martha Forero and Yolanda Silva for their continued help with the immunochemical assays.

Conflict of interest

The authors declare that they have no conflict of interest.


  1. Alba MP, Salazar LM, Puentes A, Pinto M, Torres E, Patarroyo ME (2003) 6746 SERA peptide analogues immunogenicity and protective efficacy against malaria is associated with short alpha helix formation: malaria protection associated with peptides alpha helix shortening. Peptides 24:999–1006PubMedCrossRefGoogle Scholar
  2. Alba MP, Salazar LM, Purmova J, Vanegas M, Rodriguez R, Patarroyo ME (2004) Induction and displacement of an helix in the 6725 SERA peptide analogue confers protection against P. falciparum malaria. Vaccine 22:1281–1289PubMedCrossRefGoogle Scholar
  3. Bax A, Davis DG (1985) MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J Magn Resonance 65:355–360Google Scholar
  4. Bermudez A, Reyes C, Guzman F, Vanegas M, Rosas J, Amador R, Rodriguez R, Patarroyo MA, Patarroyo ME (2007) Synthetic vaccine update: applying lessons learned from recent SPf66 malarial vaccine physicochemical, structural and immunological characterization. Vaccine 25:4487–4501PubMedCrossRefGoogle Scholar
  5. Blake MS, Johnston KH, Russell-Jones GJ, Gotschlich EC (1984) A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots. Anal Biochem 136:175–179PubMedCrossRefGoogle Scholar
  6. Cifuentes G, Bermúdez A, Rodriguez R, Patarroyo MA, Patarroyo ME (2008) Shifting the polarity of some critical residues in malarial peptides’ binding to host cells is a key factor in breaking conserved antigens’ code of silence. Med Chem 4:278–292PubMedCrossRefGoogle Scholar
  7. Cubillos M, Alba MP, Bermudez A, Trujillo M, Patarroyo ME (2003) Plasmodium falciparum SERA protein peptide analogues having short helical regions induce protection against malaria. Biochimie 85:651–657PubMedCrossRefGoogle Scholar
  8. Dessen A, Lawrence CM, Cupo S, Zaller DM, Wiley DC (1997) X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity 7:473–481PubMedCrossRefGoogle Scholar
  9. Greenfield NJ (1996) Methods to estimate the conformation of proteins and polypeptides from circular dichroism data. Anal Biochem 235:1–10PubMedCrossRefGoogle Scholar
  10. Hodder AN, Malby RL, Clarke OB, Fairlie WD, Colman PM, Crabb BS, Smith BJ (2009) Structural insights into the protease-like antigen Plasmodium falciparum SERA5 and its noncanonical active-site serine. J Mol Biol 392:154–165PubMedCrossRefGoogle Scholar
  11. Jeener J, Meier B, Backman P, Ernst R (1979) Investigation of enhance processes by two dimensional NMR spectroscopy. J Chem Phys 71:4546CrossRefGoogle Scholar
  12. Merrifield RB (1963) Automated synthesis of peptides. Solid-phase peptide synthesis, a simple and rapid synthetic method, has now been automated. J am soc 85:2149CrossRefGoogle Scholar
  13. Patarroyo ME, Patarroyo MA (2008) Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines. Acc Chem Res 41(3):377–386PubMedCrossRefGoogle Scholar
  14. Patarroyo ME, Alba MP, Vargas LE, Silva Y, Rosas J, Rodriguez R (2005) Peptides inducing short-lived antibody responses against Plasmodium falciparum malaria have shorter structures and are read in a different MHC II functional register. Biochemistry 44:6745–6754PubMedCrossRefGoogle Scholar
  15. Patarroyo ME, Bermudez A, Salazar LM, Espejo F (2006) High non-protective, long-lasting antibody levels in malaria are associated with haplotype shifting in MHC-peptide-TCR complex formation: a new mechanism for immune evasion. Biochimie 88(7):775–784PubMedCrossRefGoogle Scholar
  16. Patarroyo MA, Bermudez A, Lopez C, Yepes G, Patarroyo ME (2010a) 3D analysis of the TCR/pMHCII complex formation in monkeys vaccinated with the first peptide inducing sterilizing immunity against human malaria. PLoS One 5:e9771PubMedCrossRefGoogle Scholar
  17. Patarroyo ME, Cifuentes G, Piraján C, Moreno-Vranich A, Vanegas M (2010b) Atomic evidence that modification of H-bonds established with amino acids critical for host-cell binding induces sterile immunity against malaria. Biochem Biophys Res Commun 394:529–535PubMedCrossRefGoogle Scholar
  18. Patarroyo ME, Bermudez A, Patarroyo MA (2011) Structural and immunological principles leading to chemically synthesized, multiantigenic, multistage, minimal subunit-based vaccine development. Chem Rev 111:3459–3507PubMedCrossRefGoogle Scholar
  19. Puentes A, Garcia J, Vera R, Lopez QR, Urquiza M, Vanegas M, Salazar LM, Patarroyo ME (2000) Serine repeat antigen peptides which bind specifically to red blood cells. Parasitol Int 49:105–117PubMedCrossRefGoogle Scholar
  20. Rammensee HG, Friede T, Stevanoviic S (1995) MHC ligands and peptide motifs: first listing. Immunogenetics 41:178–228PubMedCrossRefGoogle Scholar
  21. Rance M, Sorensen OW, Bodenhausen G, Wagner G, Ernst RR, Wuthrich K (1983) Improved spectral resolution in cosy 1H NMR spectra of proteins via double quantum filtering. Biochem Biophys Res Commun 117:479–485PubMedCrossRefGoogle Scholar
  22. Rodriguez R, Moreno A, Guzman F, Calvo M, Patarroyo ME (1990) Studies in owl monkeys leading to the development of a synthetic vaccine against the asexual blood stages of Plasmodium falciparum. Am J Trop Med Hyg 43:339–354PubMedGoogle Scholar
  23. Salazar LM, Bermudez A, Patarroyo ME (2008) HLA-DR allele reading register shifting is associated with immunity induced by SERA peptide analogues. Biochem Biophys Res Commun 372:114–120PubMedCrossRefGoogle Scholar
  24. Sato D, Li J, Mitamura T, Horii T (2005) Plasmodium falciparum serine-repeat antigen (SERA) forms a homodimer through disulfide bond. Parasitol Int 54:261–265PubMedCrossRefGoogle Scholar
  25. Schueler-Furman O, Altuvia Y, Margalit H (2001) Examination of possible structural constraints of MHC-binding peptides by assessment of their native structure within their source proteins. Proteins 45:47–54PubMedCrossRefGoogle Scholar
  26. Sinigaglia F, Romagnoli P, Guttinger M, Takacs B, Pink JR (1991) Selection of T cell epitopes and vaccine engineering. Methods Enzymol 203:370–386PubMedCrossRefGoogle Scholar
  27. Suarez CF, Patarroyo ME, Trujillo E, Estupinan M, Baquero JE, Parra C, Rodriguez R (2006) Owl monkey MHC-DRB exon 2 reveals high similarity with several HLA-DRB lineages. Immunogenetics 58:542–558PubMedCrossRefGoogle Scholar
  28. Vargas LE, Parra CA, Salazar LM, Guzman F, Pinto M, Patarroyo ME (2003) MHC allele-specific binding of a malaria peptide makes it become promiscuous on fitting a glycine residue into pocket 6. Biochem Biophys Res Commun 307:148–156PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Adriana Bermúdez
    • 1
    • 3
  • Armando Moreno-Vranich
    • 1
  • Manuel E. Patarroyo
    • 1
    • 2
    Email author
  1. 1.Fundación Instituto de Inmunología de Colombia (FIDIC)BogotáColombia
  2. 2.Universidad Nacional de ColombiaBogotáColombia
  3. 3.Universidad del RosarioBogotáColombia

Personalised recommendations